When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Dupilumab - Wikipedia

   en.wikipedia.org/wiki/Dupilumab

   Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis. [6] [7] [8] [4] It is also used for the treatment of eosinophilic esophagitis, [9] prurigo nodularis [10] and ...

3. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab.

4. Calcitonin gene-related peptide receptor antagonist - Wikipedia

   en.wikipedia.org/wiki/Calcitonin_gene-related...

   As of February 2020, eptinezumab (Vyepti) was approved by the FDA for the treatment of migraine via intravenous infusion as well. [26] Three small-molecule antagonists have been approved for treatment of migraine: ubrogepant, rimegepant, and atogepant. [4] [3] [5] Ubrogepant and rimegepant are approved for acute treatment.

5. Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

   www.aol.com/news/us-fda-approves-sanofi...

   (Reuters) -The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the ...

6. AbbVie's skin disease drug found to be more effective than ...

   www.aol.com/news/abbvies-skin-disease-drug-found...

   Rinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent, the ...

7. Eptinezumab - Wikipedia

   en.wikipedia.org/wiki/Eptinezumab

   Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. [6] It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. [6] [8] It is administered by intravenous infusion. [6]